Jonathan C H Chan

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 16

Top Topics

Atrial Fibrillation

Cardiovascular Events

Helicobacter Pylori

Top Venues

Current cardiology reviews

Medicina (Kaunas, Lithuania)

Journal of cardiovascular development and disease

Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan C H Chan, Areeb Siddiqui
Pharmacological Treatment of Heart Failure: Recent Advances. Current cardiology reviews 20 (2) (2024)
Jonathan C H Chan, Areeb Siddiqui
Pharmacological Treatment of Heart Failure: Recent Advances. Current cardiology reviews 20 (2) (2024)
Jonathan C H Chan, Areeb Siddiqui
Pharmacological Treatment of Heart Failure: Recent Advances. Current cardiology reviews (2024)
Kaitlyn E Watson, Jonathan C H Chan, Bo Pan, Yazid N Alhamarneh, Ross T Tsuyuki
Enhancing hypertension detection and control through a hypertension certification program for pharmacists: A cluster randomized trial (The R x PATH Study). Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC 157 (4) (2024)
Kaitlyn E Watson, Jonathan C H Chan, Bo Pan, Yazid N Alhamarneh, Ross T Tsuyuki
Enhancing hypertension detection and control through a hypertension certification program for pharmacists: A cluster randomized trial (The R x PATH Study). Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC 157 (4) (2024)
Jonathan C H Chan, Areeb Siddiqui
Pharmacological Treatment of Heart Failure: Recent Advances. Current cardiology reviews 20 (2) (2024)
Jonathan C H Chan, Areeb Siddiqui
Pharmacological Treatment of Heart Failure: Recent Advances. Current cardiology reviews 20 (2) (2024)
Jonathan C H Chan, Michael C Y Chan
SGLT2 Inhibitors: The Next Blockbuster Multifaceted Drug? Medicina (Kaunas, Lithuania) 59 (2) (2023)
Jonathan C H Chan, Emily Cowley, Michael Chan
Practical Pharmacological Treatment of Heart Failure: Does Ejection Fraction Matter Anymore? Journal of cardiovascular development and disease 10 (3) (2023)
Jonathan C H Chan, Michael C Y Chan
SGLT2 Inhibitors: The Next Blockbuster Multifaceted Drug? Medicina (Kaunas, Lithuania) 59 (2) (2023)
Jonathan C H Chan, Michael C Y Chan
SGLT2 Inhibitors: The Next Blockbuster Multifaceted Drug? Medicina (Kaunas, Lithuania) 59 (2) (2023)
Jonathan C H Chan, Michael C Y Chan
SGLT2 Inhibitors: The Next Blockbuster Multifaceted Drug? Medicina (Kaunas, Lithuania) 59 (2) (2023)
Jonathan C H Chan, Michael C Y Chan
SGLT2 Inhibitors: The Next Blockbuster Multifaceted Drug? Medicina (Kaunas, Lithuania) 59 (2) (2023)
Jonathan C H Chan, Emily Cowley, Michael Chan
Practical Pharmacological Treatment of Heart Failure: Does Ejection Fraction Matter Anymore? Journal of cardiovascular development and disease 10 (3) (2023)
Jonathan C H Chan, Emily Cowley, Michael Chan
Practical Pharmacological Treatment of Heart Failure: Does Ejection Fraction Matter Anymore? Journal of cardiovascular development and disease 10 (3) (2023)
Jonathan C H Chan, Emily Cowley, Michael Chan
Practical Pharmacological Treatment of Heart Failure: Does Ejection Fraction Matter Anymore? Journal of cardiovascular development and disease 10 (3) (2023)